Recruiting

Studien-Nr. CN012-0034 | NCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Zusammenfassung

The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.

Participants must be 55 to 90 years of age, inclusive, at the time of Screening (Visit 1).
Participants must be diagnosed with Alzheimer's disease in accordance with the 2024 revised criteria for diagnosis and staging of Alzheimer's Disease: Alzheimer's Association Workgroup.
Participants must have a magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain (completed within the past 5 years) taken during or subsequent to the onset of dementia to rule out other central nervous system (CNS) disease that could account for the dementia syndrome, eg, major stroke, neoplasm, subdural hematoma.
Participants must have a history of psychotic symptoms (meeting International Psychogeriatric Association criteria) for at least 2 months prior to Screening (Visit 1) (participants may or may not have symptoms of agitation).

Participants must not have psychotic symptoms that are primarily attributable to a condition other than the AD causing the dementia, eg, schizophrenia, schizoaffective disorder, delusional disorder, or mood disorder with psychotic features.
Participants must not have history of major depressive episode with psychotic features during the 12 months prior to Screening, or history of bipolar disorder, schizophrenia, or schizoaffective disorder.
Participants must not have certain safety concerns, including certain laboratory test irregularities.

Zusätzliche Informationen*

Studienarme

Experimental: KarXT + KarX-EC Arm

ZUGEWIESENE BEHANDLUNG

Studienarme

Placebo Comparator: Placebo

ZUGEWIESENE BEHANDLUNG

Prüfen Sie, ob eine der klinischen Studien für Sie infrage kommt

Kommt die Studie für Sie infrage

Beantworten Sie einige Fragen zu Ihrer Gesundheit, um festzustellen, ob diese Studie für Sie infrage kommt

Geeignete Studie

Wenn ihnen eine passende Studie angezeigt wird, klicken Sie auf die Studie, damit Sie die Liste der Prüfzentren angezeigt bekommen.

Wählen Sie einen Prüfzentrumsstandort aus

Wählen Sie einen Prüfzentrumsstandort aus, der für Sie günstig ist

Registrieren

Geben Sie Ihre Kontaktdaten ein, damit das Prüfzentrum mit Ihnen Kontakt aufnehmen kann.